Cost analysis of the management of brain metastases in patients with advanced ALK+ NSCLC: alectinib versus crizotinib

por Isla, Dolores, Massuti, Bartomeu, Lázaro, Martín, de Alda, Lucía Ruiz, Gordo, Rocio, Ortega-Joaquín, Nuria, Oyagüez, Itziar
Publicado 2020

Prognostic factors for survival in patients with metastatic lung adenocarcinoma: An analysis of the SEER database

por Campos‐Balea, Begoña, de Castro Carpeño, Javier, Massutí, Bartomeu, Vicente‐Baz, David, Pérez Parente, Diego, Ruiz‐Gracia, Pedro, Crama, Leonardo, Cobo Dols, Manuel
Publicado 2020

The predictive value of 53BP1 and BRCA1 mRNA expression in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy

por Bonanno, Laura, Costa, Carlota, Majem, Margarita, Sanchez, Jose Javier, Gimenez-Capitan, Ana, Rodriguez, Ignacio, Vergenegre, Alain, Massuti, Bartomeu, Favaretto, Adolfo, Rugge, Massimo, Pallares, Cinta, Taron, Miquel, Rosell, Rafael
Publicado 2013

Combinatory effect of BRCA1 and HERC2 expression on outcome in advanced non-small-cell lung cancer

por Bonanno, Laura, Costa, Carlota, Majem, Margarita, Sanchez, Jose-Javier, Rodriguez, Ignacio, Gimenez-Capitan, Ana, Molina-Vila, Miquel Angel, Vergnenegre, Alain, Massuti, Bartomeu, Favaretto, Adolfo, Rugge, Massimo, Pallares, Cinta, Taron, Miquel, Rosell, Rafael
Publicado 2016

Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study

por Garcia-Alfonso, Pilar, Chaves, Manuel, Muñoz, Andrés, Salud, Antonieta, García-Gonzalez, Maria, Grávalos, Cristina, Massuti, Bartomeu, González-Flores, Encarna, Queralt, Bernardo, López-Ladrón, Amelia, Losa, Ferran, Gómez, Maria Jose, Oltra, Amparo, Aranda, Enrique
Publicado 2015

Antiproliferative effects of lanreotide autogel in patients with progressive, well-differentiated neuroendocrine tumours: a Spanish, multicentre, open-label, single arm phase II st...

por Martín-Richard, Marta, Massutí, Bartomeu, Pineda, Eva, Alonso, Vicente, Marmol, Maribel, Castellano, Daniel, Fonseca, Emilio, Galán, Antonio, Llanos, Marta, Sala, Maria Angeles, Pericay, Carlos, Rivera, Fernando, Sastre, Javier, Segura, Ángel, Quindós, Maria, Maisonobe, Pascal
Publicado 2013

Prognostic value of quantitative ctDNA levels in non small cell lung cancer patients

por Provencio, Mariano, Torrente, María, Calvo, Virginia, Pérez-Callejo, David, Gutiérrez, Lourdes, Franco, Fernando, Pérez-Barrios, Clara, Barquín, Miguel, Royuela, Ana, García-García, Francisco, Bueno, Coralia, Garcia-Grande, Aranzazu, Camps, Carlos, Massuti, Bartomeu, Sotomayor, Eduardo, Romero, Atocha
Publicado 2017

Phase II Trial of Atezolizumab Combined With Carboplatin and Pemetrexed for Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer With Untreated Brain Metastases (Atezo-Bra...

por Nadal, Ernest, Rodríguez-Abreu, Delvys, Simó, Marta, Massutí, Bartomeu, Juan, Oscar, Huidobro, Gerardo, López, Rafael, De Castro, Javier, Estival, Anna, Mosquera, Joaquín, Sullivan, Ivana, Felip, Enriqueta, Blasco, Ana, Guirado, Maria, Pereira, Eva, Vilariño, Noelia, Navarro, Valentín, Bruna, Jordi
Publicado 2023

Role of Kras Status in Patients with Metastatic Colorectal Cancer Receiving First-Line Chemotherapy plus Bevacizumab: A TTD Group Cooperative Study

por Díaz-Rubio, Eduardo, Gómez-España, Auxiliadora, Massutí, Bartomeu, Sastre, Javier, Reboredo, Margarita, Manzano, José Luis, Rivera, Fernando, Safont, MªJosé, Montagut, Clara, González, Encarnación, Benavides, Manuel, Marcuello, Eugenio, Cervantes, Andrés, Martínez de Prado, Purificación, Fernández-Martos, Carlos, Arrivi, Antonio, Bando, Inmaculada
Publicado 2012

Tumour location and efficacy of first-line EGFR inhibitors in KRAS/RAS wild-type metastatic colorectal cancer: retrospective analyses of two phase II randomised Spanish TTD trials

por Benavides, Manuel, Díaz-Rubio, Eduardo, Carrato, Alfredo, Abad, Albert, Guillén, Carmen, Garcia-Alfonso, Pilar, Gil, Silvia, Cano, María Teresa, Safont, María José, Gravalos, Cristina, Manzano, José Luis, Sánchez, Antonio, Alcaide, Julia, López, Rafael, Massutí, Bartomeu, Sastre, Javier, Martínez, Eva, Escudero, Pilar, Méndez, Miguel, Aranda, Enrique
Publicado 2019

Real-world treatment patterns and survival outcomes for patients with stage III non-small cell lung cancer in Spain: a nationwide cohort study

por Provencio, Mariano, Carcereny, Enric, López Castro, Rafael, Calvo, Virginia, Rodríguez Abreu, Delvys, Cobo, Manuel, Ortega, Ana Laura, Bernabé, Reyes, Guirado, Maria, Massutí, Bartomeu, del Barco-Morillo, Edel, Bosch-Barrera, Joaquim, Camps, Carlos, Carroll, Robert, Rault, Caroline, Chaib, Carlos, Penrod, John, Vo, Lien, Ralphs, Eleanor, Daumont, Melinda J.
Publicado 2023

Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer

por Simonetti, Sara, Molina, Miguel Angel, Queralt, Cristina, de Aguirre, Itziar, Mayo, Clara, Bertran-Alamillo, Jordi, Sanchez, José Javier, Gonzalez-Larriba, Jose Luis, Jimenez, Ulpiano, Isla, Dolores, Moran, Teresa, Viteri, Santiago, Camps, Carlos, Garcia-Campelo, Rosario, Massuti, Bartomeu, Benlloch, Susana, y Cajal, Santiago Ramon, Taron, Miquel, Rosell, Rafael
Publicado 2010

NGS‐based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment

por Sánchez‐Herrero, Estela, Serna‐Blasco, Roberto, Ivanchuk, Vadym, García‐Campelo, Rosario, Dómine Gómez, Manuel, Sánchez, José M., Massutí, Bartomeu, Reguart, Noemi, Camps, Carlos, Sanz‐Moreno, Sandra, Calabuig‐Fariñas, Silvia, Jantus‐Lewintre, Eloísa, Arnal, Magdalena, Fernández‐Orth, Dietmar, Calvo, Virginia, González‐Rumayor, Víctor, Provencio, Mariano, Romero, Atocha
Publicado 2021

Biomarkers Associated with Regorafenib First-Line Treatment Benefits in Metastatic Colorectal Cancer Patients: REFRAME Molecular Study

por Conde, Elisa, Earl, Julie, Crespo-Toro, Lorena, Blanco-Agudo, Carolina, Ramos-Muñoz, Edurne, Rodríguez-Serrano, E. Macarena, Martínez Ávila, Jose Carlos, Salinas-Muñoz, Laura, Serrano-Huertas, Silvia, Ferreiro, Reyes, Rodriguez-Garrote, Mercedes, Sainz, Bruno, Massuti, Bartomeu, Alfonso, Pilar García, Benavides, Manuel, Aranda, Enrique, García-Bermejo, María Laura, Carrato, Alfredo
Publicado 2021

First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled Analysis

por García-Alfonso, Pilar, Díaz-Rubio, Eduardo, Abad, Albert, Carrato, Alfredo, Massutí, Bartomeu, Ortiz-Morales, María José, Manzano Mozo, José Luis, Muñoz, Andrés, Durán, Gema, Sastre, Javier, Safont, María José, Ferreiro, Reyes, Rivera, Fernando, González, Encarnación, Valladares-Ayerbes, Manuel, Grávalos, Cristina, Alonso-Orduña, Vicente, Viéitez, José María, Yubero, Alfonso, Aranda, Enrique
Publicado 2021

Spanish Lung Cancer Group SCAT trial: surgical audit to lymph node assessment based on IASLC recommendations

por Jarabo Sarceda, José Ramón, Bolufer Nadal, Sergio, Mongil Poce, Roberto, López de Castro, Pedro, Moreno Balsalobre, Ramón, Peñalver Cuesta, Juan Carlos, Embún Flor, Raul, Pac Ferrer, Joaquín, Algar Algar, Francisco Javier, Gámez García, Antonio Pablo, Jiménez, Marcelo F., Sales-Badía, Jesús Gabriel, Pereira, Eva, Massuti, Bartomeu, Provencio, Mariano, Hernando Trancho, Florentino
Publicado 2021

LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology

por Garrido, Pilar, Paz‐Ares, Luis, Majem, Margarita, Morán, Teresa, Trigo, José Manuel, Bosch‐Barrera, Joaquim, Garcίa‐Campelo, Rosario, González‐Larriba, José Luis, Sánchez‐Torres, José Miguel, Isla, Dolores, Viñolas, Núria, Camps, Carlos, Insa, Amelia, Juan, Óscar, Massuti, Bartomeu, Paredes, Alfredo, Artal, Ángel, López‐Brea, Marta, Palacios, José, Felip, Enriqueta
Publicado 2021

Epidemiology, treatment, and survival in small cell lung cancer in Spain: Data from the Thoracic Tumor Registry

por Franco, Fernando, Carcereny, Enric, Guirado, Maria, Ortega, Ana L., López-Castro, Rafael, Rodríguez-Abreu, Delvys, García-Campelo, Rosario, del Barco, Edel, Juan, Oscar, Aparisi, Francisco, González-Larriba, Jose L., Domine, Manuel, Trigo, Jose M., Cobo, Manuel, Cerezo, Sara, Calzas, Julia, Massutí, Bartomeu, Bosch-Barrera, Joaquim, García Coves, Paola, Domènech, Marta, Provencio, Mariano
Publicado 2021

Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer

por Dalgleish, Angus G, Stebbing, Justin, Adamson, Douglas JA, Arif, Seema Safia, Bidoli, Paolo, Chang, David, Cheeseman, Sue, Diaz-Beveridge, Robert, Fernandez-Martos, Carlos, Glynne-Jones, Rob, Granetto, Cristina, Massuti, Bartomeu, McAdam, Karen, McDermott, Raymond, Martín, Andrés J Muñoz, Papamichael, Demetris, Pazo-Cid, Roberto, Vieitez, Jose M, Zaniboni, Alberto, Carroll, Kevin J, Wagle, Shama, Gaya, Andrew, Mudan, Satvinder S
Publicado 2016

Atezolizumab Plus Bevacizumab as First-line Treatment for Patients With Metastatic Nonsquamous Non–Small Cell Lung Cancer With High Tumor Mutation Burden: A Nonrandomized Controlle...

por Provencio, Mariano, Ortega, Ana Laura, Coves-Sarto, Juan, Calvo, Virginia, Marsé-Fabregat, Raquel, Dómine, Manuel, Guirado, María, Carcereny, Enric, Fernández, Natalia, Álvarez, Ruth, Blanco, Remei, León-Mateos, Luis, Sánchez-Torres, José Miguel, Sullivan, Ivana Gabriela, Cobo, Manuel, Sánchez-Hernández, Alfredo, Massuti, Bartomeu, Sierra-Rodero, Belen, Mártinez-Toledo, Cristina, Serna-Blasco, Roberto, Romero, Atocha, Cruz-Bermúdez, Alberto
Publicado 2022